398 related articles for article (PubMed ID: 10491408)
1. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes.
Kim YB; Nikoulina SE; Ciaraldi TP; Henry RR; Kahn BB
J Clin Invest; 1999 Sep; 104(6):733-41. PubMed ID: 10491408
[TBL] [Abstract][Full Text] [Related]
2. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.
Kim YB; Kotani K; Ciaraldi TP; Henry RR; Kahn BB
Diabetes; 2003 Aug; 52(8):1935-42. PubMed ID: 12882908
[TBL] [Abstract][Full Text] [Related]
3. In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes.
Chun KH; Choi KD; Lee DH; Jung Y; Henry RR; Ciaraldi TP; Kim YB
Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E536-42. PubMed ID: 21189360
[TBL] [Abstract][Full Text] [Related]
4. Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats.
Kim YB; Peroni OD; Franke TF; Kahn BB
Diabetes; 2000 May; 49(5):847-56. PubMed ID: 10905496
[TBL] [Abstract][Full Text] [Related]
5. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
Kim YB; Zhu JS; Zierath JR; Shen HQ; Baron AD; Kahn BB
Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307
[TBL] [Abstract][Full Text] [Related]
6. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes.
Vind BF; Birk JB; Vienberg SG; Andersen B; Beck-Nielsen H; Wojtaszewski JF; Højlund K
Diabetologia; 2012 May; 55(5):1435-45. PubMed ID: 22322917
[TBL] [Abstract][Full Text] [Related]
8. Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].
Storgaard H; Song XM; Jensen CB; Madsbad S; Björnholm M; Vaag A; Zierath JR
Diabetes; 2001 Dec; 50(12):2770-8. PubMed ID: 11723060
[TBL] [Abstract][Full Text] [Related]
9. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
Nikoulina SE; Ciaraldi TP; Mudaliar S; Mohideen P; Carter L; Henry RR
Diabetes; 2000 Feb; 49(2):263-71. PubMed ID: 10868943
[TBL] [Abstract][Full Text] [Related]
10. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
[TBL] [Abstract][Full Text] [Related]
11. Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activation.
Nikoulina SE; Ciaraldi TP; Carter L; Mudaliar S; Park KS; Henry RR
J Clin Endocrinol Metab; 2001 Sep; 86(9):4307-14. PubMed ID: 11549666
[TBL] [Abstract][Full Text] [Related]
12. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
[TBL] [Abstract][Full Text] [Related]
13. Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2005 Aug; 54(8):2351-9. PubMed ID: 16046301
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle insulin resistance in obesity-associated type 2 diabetes in monkeys is linked to a defect in insulin activation of protein kinase C-zeta/lambda/iota.
Standaert ML; Ortmeyer HK; Sajan MP; Kanoh Y; Bandyopadhyay G; Hansen BC; Farese RV
Diabetes; 2002 Oct; 51(10):2936-43. PubMed ID: 12351430
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.
Kruszynska YT; Worrall DS; Ofrecio J; Frias JP; Macaraeg G; Olefsky JM
J Clin Endocrinol Metab; 2002 Jan; 87(1):226-34. PubMed ID: 11788651
[TBL] [Abstract][Full Text] [Related]
16. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action.
Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Mandarino LJ
J Appl Physiol (1985); 2003 Dec; 95(6):2519-29. PubMed ID: 12909611
[TBL] [Abstract][Full Text] [Related]
17. Akt2 influences glycogen synthase activity in human skeletal muscle through regulation of NH₂-terminal (sites 2 + 2a) phosphorylation.
Friedrichsen M; Birk JB; Richter EA; Ribel-Madsen R; Pehmøller C; Hansen BF; Beck-Nielsen H; Hirshman MF; Goodyear LJ; Vaag A; Poulsen P; Wojtaszewski JF
Am J Physiol Endocrinol Metab; 2013 Mar; 304(6):E631-9. PubMed ID: 23321478
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats.
Ogihara T; Asano T; Ando K; Chiba Y; Sekine N; Sakoda H; Anai M; Onishi Y; Fujishiro M; Ono H; Shojima N; Inukai K; Fukushima Y; Kikuchi M; Fujita T
Diabetes; 2001 Mar; 50(3):573-83. PubMed ID: 11246877
[TBL] [Abstract][Full Text] [Related]
19. Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats.
Song XM; Kawano Y; Krook A; Ryder JW; Efendic S; Roth RA; Wallberg-Henriksson H; Zierath JR
Diabetes; 1999 Mar; 48(3):664-70. PubMed ID: 10078575
[TBL] [Abstract][Full Text] [Related]
20. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects.
Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Kashyap S; Mandarino LJ
Metabolism; 2004 Sep; 53(9):1233-42. PubMed ID: 15334390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
